Welcome to the Multiple Sclerosis Resource Centre. The Resource Centre provides you with free access to the latest peer-reviewed clinical information relating to the treatment of Multiple Sclerosis.
What is a Resource Centre?
A Resource Centre is a freely accessible platform that aims to increase clinical knowledge in a specific medical specialty by disseminating important new research and clinical developments more broadly. All content on this platform is independently selected and reviewed by the Resource Centre’s editor, Professor Tim Vartanian from Cornell University. This resource is provided by the journal, Multiple Sclerosis and Related Disorders, published by Elsevier, and made possible by a donation from EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany and from Pfizer Inc.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing–remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS
Xiangyi Meng, Peter S. Chin, Ron Hashmonay, M. Zahur Islam, Gary Cutter
Contemporary Clinical Trials, pages 69 - 74
Yuan Zhou, Bruce Taylor, Ingrid van der Mei, Niall Stewart, Jac Charlesworth, Leigh Blizzard, Anne-Louise Ponsonby, Terence Dwyer, Fotini Pittas, Steve Simpson Jr.
Journal of the Neurological Sciences, 1-2, 349, pages 40 - 44
About the Editors
- Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
- Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...
- Nov 20149Nov 201413The International Society for NeuroImmunology (ISNI) is organizing the 12th International Congress of NeuroImmunology (ISNI 2014) together with the 14th...
- Nov 201415Nov 201419The Society for Neuroscience (SfN) was founded in 1969. With nearly 42,000 members in more than 90 countries SfN is...
- Jan 201525Jan 201530
- Feb 20153Feb 20158